Humane Genomics
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $0.1M
Investors
- 2
About Humane Genomics
Based in New York, US, and founded in 2019 by CEO Peter Weijmarshausen, Chad Moles, and Andrew Hessel, Humane Genomics Inc operates as a biotechnology company that focuses on the development of a virus development platform that develops artificial viruses to cure diseases. The company develops precision-designed oncolytic viral therapies, utilizing synthetic biology to engineer viruses that can effectively kill cancer cells. Using DNA synthesis and lab robotics, the company's platform creates an oncolytic virus that is customized for various tumor types using a proprietary design and digital library. This allows patients to receive safe and effective therapies for cancer cells taken from their biopsy. In addition, the technology used by the company can 3D print or synthesize DNA based on a computer file.
Who invested in Humane Genomics
2 investors across 2 rounds
See all investors in Humane Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Humane Genomics
Who invested in Humane Genomics?
Humane Genomics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Humane Genomics raised?
Humane Genomics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Humane Genomics last raise money?
Humane Genomics's most recent round on record is a Seed, in Feb 2025.
What does Humane Genomics do?
Based in New York, US, and founded in 2019 by CEO Peter Weijmarshausen, Chad Moles, and Andrew Hessel, Humane Genomics Inc operates as a biotechnology company that focuses on the development of a virus development platform that develops artificial viruses to cure diseases.
Where is Humane Genomics headquartered?
Humane Genomics is headquartered in New York, US.
Which VCs invest in companies like Humane Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Humane Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Humane Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.